polymarket
Weather
Hantavirus vaccine in 2026?
6%
implied YES probability
Price history
Last 45 days ·
High 12% ·
Low 6%
· 7d 0.0pp
· 30d -38.9pp
How this market resolves
This market will resolve to "Yes" if any vaccine intended for humans and inoculating against Hantavirus (including Hantavirus Pulmonary Syndrome (HPS) or Hemorrhagic Fever with Renal Syndrome (HFRS)) receives full approval from the U.S. Food and Drug Administration between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The primary resolution source for this market will be official information from the FDA, including its list of approved vaccines (https://www.fda.gov/vaccines-blood-biologics/vaccines/vaccines-licensed-use-united-states), however a consensus of credible reporting may also be used.
Trade on Polymarket
Open on Polymarket
Frenzy Capital does not execute trades on prediction markets — we aggregate
public order-book and trading data for analysis.
Prediction market data reflects speculative event probabilities, not guaranteed outcomes. This is not investment advice. See Terms §17.